<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lidocaine and menthol: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lidocaine and menthol: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Lidocaine and menthol: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="108200" href="/d/html/108200.html" rel="external">see "Lidocaine and menthol: Patient drug information"</a> and <a class="drug drug_general" data-topicid="114508" href="/d/html/114508.html" rel="external">see "Lidocaine and menthol: Drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F27004038"><span class="drugH1">Brand Names: US</span>
<ul>
<li>1st Relief Spray [OTC] [DSC];</li>
<li>Asperflex Max [OTC];</li>
<li>AvaDERM [OTC];</li>
<li>AvaLin [OTC] [DSC];</li>
<li>CBD4 Freeze Pump Maximum Str [OTC] [DSC];</li>
<li>CBD4 Freeze Pump Vanish Scent [OTC];</li>
<li>Elemar Patch;</li>
<li>Exigence One Patch [OTC] [DSC];</li>
<li>Gen7T Plus;</li>
<li>LevigoLT [OTC];</li>
<li>Lidocaine Plus Menthol [OTC];</li>
<li>LidoMet-10 [OTC] [DSC];</li>
<li>LidoPatch Pain Relief [OTC];</li>
<li>LidoStream;</li>
<li>Lidothol;</li>
<li>Lidotral-Menthol;</li>
<li>LidozenGel [OTC];</li>
<li>LidozenPatch [OTC];</li>
<li>Limencin [OTC];</li>
<li>LM Plus Relief;</li>
<li>MaL Patch;</li>
<li>MenthoReal-10 [OTC] [DSC];</li>
<li>NuLido [OTC];</li>
<li>Point Relief Lidospot [OTC];</li>
<li>Prolida [OTC];</li>
<li>Siterol [OTC];</li>
<li>Synvexia TC [DSC];</li>
<li>Terocin [OTC];</li>
<li>Transderm-iQ [OTC] [DSC];</li>
<li>ValleMent [OTC] [DSC];</li>
<li>Venia [OTC];</li>
<li>Zeruvia;</li>
<li>Zylotrol Plus [OTC] [DSC];</li>
<li>Zylotrol [OTC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F55504535"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Analgesic, Topical</span>;</li>
<li>
<span class="list-set-name">Local Anesthetic</span></li></ul></div>
<div class="block dop drugH1Div" id="F50511775"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5d63ef08-9306-446a-93f5-3897ac44f47b">Topical anesthetic</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical anesthetic:</b>
<b> Note</b>: Approved ages may vary with product, manufacturer, and market changes; consult labeling for specific information.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Prescription products:</i> Product-specific labeling:</p>
<p style="text-indent:-2em;margin-left:6em;">Ointment: Lidostream kit (lidocaine 5%/menthol 10% liquid): Children and Adolescents: Topical: For use on skin or oral mucous membranes; use lowest effective dose. Do not exceed lidocaine doses: 4.5 mg/kg/dose; maximum dose: 300 mg/dose; applied with cotton applicator, cotton pack, or gauze.</p>
<p style="text-indent:-2em;margin-left:6em;">Patch: eg, Gen 7T Plus (lidocaine 3.5%/menthol 7%): Children ≥12 years and Adolescents: Topical: Apply 1 patch/day to affected area; remove patch after 12 hours of continuous use.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>OTC products:</i> Product-specific labeling:</p>
<p style="text-indent:-2em;margin-left:6em;">Cream:</p>
<p style="text-indent:-2em;margin-left:8em;">AvaDERM (lidocaine 4%/menthol 1%): Children ≥2 years and Adolescents: Topical: Apply a thin film to the affected area up to 3 to 4 times daily.</p>
<p style="text-indent:-2em;margin-left:8em;">CBD Freeze Pump, Icy Hot Lidocaine Plus Menthol (lidocaine 4%/menthol 1%): Adolescents: Topical: Apply to affected area every 6 to 8 hours; do not exceed 3 applications/24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Spray: eg, 1<sup>st</sup> Relief (lidocaine 4%/menthol 1%): Children ≥2 years and Adolescents: Topical: Apply to affected areas up to 4 times daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Patch:</p>
<p style="text-indent:-2em;margin-left:8em;">Lidozen, Siterol (lidocaine 4%/menthol 1%): Children ≥12 years and Adolescents: Topical: Apply 1 patch to affected area; remove patch after 8 hours of continuous use; maximum daily dose: 4 patches/<b>day</b>; do not use patch longer than 5 consecutive days.</p>
<p style="text-indent:-2em;margin-left:8em;">Terocin (lidocaine 4%/menthol 4%): Children ≥12 years and Adolescents: Topical: Apply 1 patch to affected area once or twice daily.</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dorp drugH1Div" id="F51159620"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51159621"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F50511760"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="114508" href="/d/html/114508.html" rel="external">see "Lidocaine and menthol: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="eb479ed7-37f7-495a-84af-a27b520b54df">Anesthetic</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anesthetic:</b>
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>OTC products:</b></p>
<p style="text-indent:-2em;margin-left:6em;">Cream: Apply a thin film to the affected area 3 to 4 times daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Gel, spray: Apply to affected areas ≤4 times daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Patch: <b>Note:</b> Additional patch products may be available with different frequency and duration of application instructions; also refer to manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:8em;">Avalin, Lidozen: Apply patch to affected area ≤4 times daily. Patch may remain in place for up to 8 hours. Do not use for &gt;5 consecutive days.</p>
<p style="text-indent:-2em;margin-left:8em;">LenzaPro: Apply patch to affected area. Patch may remain in place for up to 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">LidoPatch: Apply patch to affected area. Patch may remain in place for up to 12 hours (maximum: 1 patch/24 hours).</p>
<p style="text-indent:-2em;margin-left:8em;">Siterol: Apply patch to affected area. Patch may remain in place for up to 8 hours (maximum: 4 patches/24 hours). Do not use &gt;5 consecutive days.</p>
<p style="text-indent:-2em;margin-left:8em;">Terocin: Apply patch to affected area once or twice daily.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Rx products:</b></p>
<p style="text-indent:-2em;margin-left:6em;">Cream: Apply a thin film to the affected area 2 or 3 times daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Gel: Apply to affected area up to 4 times daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Patch: Lidothol: Apply patch to affected area. Patch may remain in place for up to 12 hours (maximum: 4 patches/24 hours).</p>
<p style="text-indent:-2em;margin-left:6em;">Spray: Apply to the affected area 2 or 3 times daily or as directed by a health care provider; consider smaller areas of treatment in debilitated patients.</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50990317"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">There are no dosage adjustments provided in the manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Spray (Rx): There are no dosage adjustments provided in the manufacturer's labeling. Consider smaller areas of treatment in patients with altered kidney function.</p></div>
<div class="block doha drugH1Div" id="F50987653"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F50540252"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Also see Lidocaine monograph. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Central nervous system: Burning sensation, localized warm feeling, paresthesia (localized), stinging sensation</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Localized erythema</p>
<p style="text-indent:-2em;margin-left:2em;">Local: Localized edema</p></div>
<div class="block coi drugH1Div" id="F50511736"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to lidocaine, menthol, local anesthetic of the amide type, or any component of the formulation; secondary bacterial infection at application site; traumatized mucosa. Contraindications may vary by product/formulation; also refer to manufacturer's labeling.</p></div>
<div class="block war drugH1Div" id="F50511737"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity: Use with caution in patients with known drug sensitivities. Allergic reactions (cutaneous lesions, urticaria, edema, or anaphylactoid reactions) may be a result of sensitivity to lidocaine (rare) or preservatives used in formulations. Patients allergic to para-aminobenzoic acid derivatives (eg, procaine, tetracaine, benzocaine) have not shown cross sensitivity to lidocaine.</p>
<p style="text-indent:-2em;margin-left:4em;">• Local effects: Irritation, sensitivity, burns (rare), and/or infection may occur at the site of application; discontinue use and institute appropriate therapy if local effects occur.</p>
<p style="text-indent:-2em;margin-left:4em;">• Methemoglobinemia: Has been reported with local anesthetics; clinically significant methemoglobinemia requires immediate treatment along with discontinuation of the anesthetic and other oxidizing agents. Onset may be immediate or delayed (hours) after anesthetic exposure. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, exposure to oxidizing agents or their metabolites, or infants &lt;6 months of age are more susceptible and should be closely monitored for signs and symptoms of methemoglobinemia (eg, cyanosis, headache, rapid pulse, shortness of breath, lightheadedness, fatigue).</p>
<p style="text-indent:-2em;margin-left:4em;">• Systemic adverse effects: Potentially life-threatening side effects (eg, irregular heartbeat, seizures, coma, respiratory depression, death) have occurred when lidocaine is used prior to cosmetic procedures. Excessive dosing for any indication (eg, application to large areas, use above recommended dose, application to denuded or inflamed skin, applying longer than recommended), smaller patients, and/or impaired elimination may lead to increased absorption and systemic toxicity. Patient should adhere strictly to recommended dosage and administration guidelines; serious adverse effects may require the use of supportive care and resuscitative equipment; lidocaine toxicity may occur at blood concentrations &gt;5 mcg/mL.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Acutely ill patients: Use with caution; acutely ill patients should be given reduced doses commensurate with their age and physical status.</p>
<p style="text-indent:-2em;margin-left:4em;">• Debilitated patients: Use with caution; debilitated patients should be given reduced doses commensurate with their age and physical status.</p>
<p style="text-indent:-2em;margin-left:4em;">• Older adult: Use with caution; elderly patients should be given reduced doses commensurate with their age and physical status.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatic impairment: Use caution in patients with severe hepatic disease due to diminished ability to metabolize systemically absorbed lidocaine.</p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: Use with caution; children should be given reduced doses commensurate with their age and physical status.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol: Some dosage forms may contain benzyl alcohol and/or sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity ("gasping syndrome") in neonates; the "gasping syndrome" consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggest that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol and/or benzyl alcohol derivative with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson 2002; Lucente 2000; Shelley 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade 1986; CDC 1984). See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Topical gel (Rx): Avoid exposing application site to external heat sources (eg, heating pad, electric blanket). Keep away from open flame and do not heat, microwave, or add to hot water; flammable.</p>
<p style="text-indent:-2em;margin-left:4em;">• Topical patch: Avoid exposing application site to external heat sources (eg, heating pad, electric blanket, heat lamp, hot tub).</p>
<p style="text-indent:-2em;margin-left:4em;">• Topical spray (Rx): Avoid exposing application site to external heat sources (eg, heating pad, electric blanket).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): When used for self-medication, discontinue use and contact health care provider if symptoms persist &gt;7 days, condition worsens or recurs, or if rash, irritation, itching, or skin injury (eg, pain, swelling, blistering) develops. Do not use on open wounds, cuts, damaged or infected skin; in the eyes, mouth, genitals; or any other mucous membranes. Do not use in large quantities, particularly over raw or blistered areas. Some products are not recommended for use with bandages; consult specific product labeling.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F55504541"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">The FDA recommends against using topical OTC medications for teething pain as some products may cause harm; the use of OTC topical anesthetics (eg, benzocaine) for teething pain is also discouraged by AAP and The American Academy of Pediatric Dentistry (AAP 2011; AAPD 2012). The AAP recommends managing teething pain with a chilled (not frozen) teething ring or gently rubbing/massaging with the caregiver's finger.</p>
<p style="text-indent:0em;margin-top:2em;">Topical patches (both used and unused) may cause toxicities in children; used patches still contain large amounts of lidocaine; store and dispose patches out of the reach of children.</p></div>
<div class="block foc drugH1Div" id="F27004039"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">AvaDERM: Lidocaine 4% and menthol 1% (120 g) [contains cetearyl alcohol, propylene glycol, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">CBD4 Freeze Pump Maximum Str: Lidocaine 4% and menthol 1% (60 g [DSC]) [contains cetostearyl alcohol, methylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">CBD4 Freeze Pump Vanish Scent: Lidocaine 4% and menthol 1% (60 g) [contains cetostearyl alcohol, methylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LevigoLT: Lidocaine 4% and menthol 1% (76.5 g) [paraben free; contains cetearyl alcohol, disodium edta]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Synvexia TC: Lidocaine 4% and menthol 1% (60 g [DSC]) [contains cetyl alcohol, naproxen, trolamine salicylate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zylotrol: Lidocaine 4% and menthol 1% (113 g [DSC]) [contains cetostearyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zylotrol: Lidocaine 4% and menthol 1% (102 g) [contains cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Lidothol: Lidocaine 4.5% and menthol 5% (99 g) [contains sd alcohol, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidozenGel: Lidocaine 4% and menthol 1% (120 mL) [contains fd&amp;c blue #1 (brilliant blue), fd&amp;c yellow #5 (tartrazine), polysorbate 80, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">NuLido: Lidocaine 4% and menthol 1% (120 mL) [contains isopropyl alcohol, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zylotrol: Lidocaine 4% and menthol 1% (118.3 g) [contains isopropyl alcohol, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Lidocaine 4% and menthol 1% (120 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Elemar Patch: Lidocaine 5% and menthol 6% [contains disodium edta, methylparaben, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidoStream: Lidocaine 5% and menthol 10% [contains isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zylotrol Plus: Lidocaine 4% and menthol 1% [DSC] [contains methylparaben, polysorbate 80, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Liquid, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Lidotral-Menthol: Lidocaine 5% and menthol 3% (30 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1st Relief Spray: Lidocaine 4% and menthol 1% (118 mL [DSC]) [contains sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gen7T Plus: Lidocaine 3.5% and menthol 7% (120 g) [contains edetate (edta) disodium, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ointment, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Transderm-iQ: Lidocaine 4% and menthol 1% (121 g [DSC]) [contains cetyl alcohol, edetate (edta) sodium (tetrasodium), trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Patch, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Asperflex Max: Lidocaine 4% and menthol 1% (5 ea) [contains polysorbate 80, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">AvaLin: Lidocaine 4% and menthol 1% (15 ea [DSC]) [contains polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Exigence One Patch: Lidocaine 4% and menthol 1% (1 ea [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gen7T Plus: Lidocaine 3.5% and menthol 7% (10 ea, 15 ea) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Lidocaine Plus Menthol: Lidocaine 4% and menthol 1% (15 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidoPatch Pain Relief: Lidocaine 3.99 % and menthol 1.25% (3 ea) [contains disodium edta, iodopropynyl butylcarbamate, methylparaben, polysorbate 80, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidoPatch Pain Relief: Lidocaine 3.6% and menthol 1.25% (3 ea [DSC], 30 ea [DSC]) [contains disodium edta, methylparaben, polysorbate 80, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Lidothol: Lidocaine 4.5% and menthol 5% (1 ea, 15 ea) [contains propylene glycol, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidozenPatch: Lidocaine 4% and menthol 1% (5 ea [DSC]) [contains fd&amp;c blue #1 (brilliant blue), fd&amp;c yellow #5 (tartrazine), polysorbate 80, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidozenPatch: Lidocaine 4% and menthol 1% (5 ea) [contains methylparaben, polysorbate 80, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidozenPatch: Lidocaine 4% and menthol 1% (5 ea [DSC]) [contains polysorbate 80, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Limencin: Lidocaine 4% and menthol 4% (10 ea) [contains edetate (edta) disodium, iodopropynyl butylcarbamate, methylparaben, polysorbate 80, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LM Plus Relief: Lidocaine 3.5% and menthol 7% (15 ea) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">MaL Patch: Lidocaine 4% and menthol 5% (15 ea) [contains disodium edta, iodopropynyl butylcarbamate, methylparaben, polysorbate 80, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Point Relief Lidospot: Lidocaine 4% and menthol 1% (5 ea) [contains methylparaben, polysorbate 80, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Prolida: Lidocaine 4% and menthol 1% (15 ea) [contains polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Siterol: Lidocaine 3.99% and menthol 1% (15 ea) [contains fd&amp;c blue #1 (brilliant blue), fd&amp;c yellow #5 (tartrazine), polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Terocin: Lidocaine 4% and menthol 4% (10 ea) [contains edetate (edta) disodium, iodopropynyl butylcarbamate, methylparaben, polysorbate 80, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">ValleMent: Lidocaine 4% and menthol 4% (5 ea [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Venia: Lidocaine 4% and menthol 4% (10 ea) [contains polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zeruvia: Lidocaine 4% and menthol 1% (15 ea, 30 ea) [contains disodium edta, polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zylotrol: Lidocaine 4% and menthol 1% (15 ea); Lidocaine 4% and menthol 4% (15 ea [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zylotrol: Lidocaine 4% and menthol 1% (15 ea) [contains edetate (edta) disodium, polysorbate 80, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Lidocaine 4% and menthol 4% (5 ea, 10 ea [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Therapy Pack, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LidoMet-10: Lidocaine 4% and menthol 4% (10 ea [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">MenthoReal-10: Lidocaine 4% and menthol 4% (10 ea [DSC])</p></div>
<div class="block geq drugH1Div" id="F26974435"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F27265721"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Zylotrol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per gram): $4.90</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Lidocaine-Menthol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per gram): $3.96</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Lidothol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4.5-5% (per gram): $9.57</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (LidozenGel External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per mL): $4.04</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (NuLido External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per mL): $4.17</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Zylotrol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per gram): $4.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Kit</b> (Elemar Patch External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-6% (per each): $1,250.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Lidotral-Menthol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-3% (per mL): $71.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Asperflex Max External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per each): $0.92</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Gen7T Plus External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3.5-7% (per each): $63.27</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Lidocaine-Menthol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-4% (per each): $48.40</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (LidoPatch Pain Relief External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3.99-1.25% (per each): $9.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Lidothol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4.5-5% (per each): $57.11</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (LidozenPatch External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per each): $48.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (LM Plus Relief External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3.5-7% (per each): $63.27</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (NuLido External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per each): $49.93</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Point Relief Lidospot External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per each): $3.80</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Venia External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-4% (per each): $42.10</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Patch</b> (Zylotrol External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-1% (per each): $52.35</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52622746"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: For external use only; not for ophthalmic, oral, or genital use; do not use on open wounds, cuts, damaged, or infected skin or any OTC products on mucous membranes. Some products are not recommended for use with bandages; consult specific product labeling. Wash hands after application. Avoid exposing application site to external heat sources (eg, heating pad, electric blanket, heat lamp, hot tub).</p>
<p style="text-indent:-2em;margin-left:2em;">Patch: Clean and dry affected area prior to administration; remove protective film and apply. Some products (eg, Gen 7T Plus) may be cut to size of affected area; discard unused pieces.</p></div>
<div class="block adm drugH1Div" id="F50511790"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b> For external use only; not for ophthalmic, oral, or genital use; do not use on open wounds, cuts, damaged or infected skin, or on mucous membranes. Some products are not recommended for use with bandages; consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Gel (Rx): Clean and dry affected area prior to administration; wash hands after application. Clothing may be worn over treatment area. Keep away from open flame and do not heat, microwave, or add to hot water; flammable. Avoid exposing application site to external heat sources (eg, heating pad, electric blanket).</p>
<p style="text-indent:-2em;margin-left:2em;">Patch: Clean and dry affected area prior to administration; remove protective film and apply. Wash hands after application. Avoid exposing application site to external heat sources (eg, heating pad, electric blanket, heat lamp, hot tub). Some patches may be cut to a smaller size. Also refer to manufacturer’s labeling for additional product-specific administration information.</p>
<p style="text-indent:-2em;margin-left:2em;">Spray (Rx): Apply to intact skin and cover the most painful area. Avoid exposing application site to external heat sources (eg, heating pad, electric blanket). If using concomitantly with other local anesthetic agents, consider the total amount absorbed of all formulations.</p></div>
<div class="block sts drugH1Div" id="F50511743"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">OTC products: Store at room temperature. Protect from moisture and direct sunlight. Discard any used or unused patches by folding adhesive sides together and dispose of in trash away from children and pets.</p>
<p style="text-indent:-2em;margin-left:2em;">Rx products: Store at room temperature. Protect from moisture and direct sunlight. Discard any used or unused patches by folding adhesive sides together and disposing in trash away from children and pets. Refer to manufacturer's labeling for additional product-specific storage information.</p></div>
<div class="block usep drugH1Div" id="F55504538"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Approved ages may vary by product, manufacturer, and market changes; consult labeling for specific information.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Prescription products:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Gel (eg, Lidothol [lidocaine 4.5%/menthol 5%]: Relief of pain associated with arthritis, backache, cramps, discomfort, neckache, soreness, sprains, or strains (FDA approved in adults).</p>
<p style="text-indent:-2em;margin-left:4em;">Ointment (eg, Lidostream kit [lidocaine 5%/menthol liquid 10%]): Anesthesia to mucous membrane of the oropharynx; anesthetic lubricant for intubation; relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites (FDA approved in pediatric patients [age not specified] and adults).</p>
<p style="text-indent:-2em;margin-left:4em;">Patch (eg, Gen 7T Plus [lidocaine 3.5%/menthol 7%], Lidothol [lidocaine 4.5%/menthol 5%]): Relief of mild to moderate acute or chronic aches and pains of muscles and joints (eg, simple backache, lumbago, arthritis, neuralgia, strains, bruises, sprains) (FDA approved in ages ≥12 years and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>OTC products:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Cream (eg, lidocaine 4%/menthol 1%): Temporary relief of minor pain and itching associated with minor burns and cuts, scrapes, sunburn, insect bites, or skin irritations (eg, AvaDERM [FDA approved in ages ≥2 years and adults]; CBD Freeze pump, IcyHot [FDA approved in ages &gt;12 years and adults]).</p>
<p style="text-indent:-2em;margin-left:4em;">Patch:</p>
<p style="text-indent:-2em;margin-left:6em;">Lidocaine 3.99% or 4%/menthol 1% (eg, Lidozen, Siterol): Temporarily relieves minor pain associated with minor cuts, scrapes, and minor skin irritations (FDA approved in ages ≥12 years and adults).</p>
<p style="text-indent:-2em;margin-left:6em;">Lidocaine 4%/menthol 4% (eg, Terocin): Temporary relief of minor aches and muscle pains associated with arthritis, simple backache, strains, and muscle soreness and stiffness (FDA approved in ages ≥12 years and adults).</p></div>
<div class="block cyt drugH1Div" id="F27004238"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">Refer to individual components.</p></div>
<div class="block dri drugH1Div" id="F27004235"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Antiarrhythmic Agents (Class IB): Lidocaine (Topical) may enhance the adverse/toxic effect of Antiarrhythmic Agents (Class IB). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cimetidine: May increase the serum concentration of Lidocaine (Topical).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Dapsone (Topical): May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Local Anesthetics: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Local Anesthetics. Specifically, the risk for methemoglobinemia may be increased. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methemoglobinemia Associated Agents: May enhance the adverse/toxic effect of Local Anesthetics. Specifically, the risk for methemoglobinemia may be increased.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Nitric Oxide: May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents. Combinations of these agents may increase the likelihood of significant methemoglobinemia.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sodium Nitrite: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Sodium Nitrite. Combinations of these agents may increase the likelihood of significant methemoglobinemia. <i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F50511734"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Animal reproduction studies have not been conducted with this combination. See individual agents.</p></div>
<div class="block mopp drugH1Div" id="F55504546"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Monitor application site; young children for signs and symptoms of methemoglobinemia such as pallor, fatigue, cyanosis, nausea, muscle weakness, dizziness, confusion, agitation, dyspnea, and tachycardia. The classical clinical finding of methemoglobinemia is chocolate brown-colored arterial blood. However, suspected cases should be confirmed by co-oximetry, which yields a direct and accurate measure of methemoglobin levels. Standard pulse oximetry readings or arterial blood gas values are not reliable. Clinically significant methemoglobinemia requires immediate treatment.</p></div>
<div class="block pha drugH1Div" id="F50511744"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:-2em;margin-left:2em;">Lidocaine: Blocks both initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction.</p>
<p style="text-indent:-2em;margin-left:2em;">Menthol: Dilates the blood vessels, causing a sensation of coldness followed by an analgesic effect; relieves itching.</p></div>
<div class="block phk drugH1Div" id="F50511745"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Refer to individual agents.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58211380"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">1st relief | Aflexeryl lc | Atendia | Avaderm | Avalin pain relieving patch | Avalin rx | Cbd4 freeze pump vanishing scent | Endoxcin | Exigence one patch | Gen7t plus | Icy hot lidocaine | Icy hot max lidocaine | Lenza pro | Lenzagel | Lenzapatch | Lenzapro | Lidenza patch | Lidocaine 4% menthol 4% | Lidocaine plus menthol | Lidodextrapine | Lidomet 10 | Lidopatch | Lidothol | Lidozengel | Limencin | Lmr plus | Max freeze | Menthoreal | Mtx patch | Nulido | Point relief lidospot | Prolida Patch | Releevia LM | Relyyks | Zylotrol | Zylotrol maximum pain</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  1<sup>st</sup> Relief Spray (lidocaine and menthol) [prescribing information]. Los Angeles, CA: 1<sup>st</sup> Class Pharmaceuticals; May 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319. DOI: 10.1067/mpd.2001.116281<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3960626">
<a name="3960626"></a>Alade SL, Brown RE, Paquet A Jr. Polysorbate 80 and E-Ferol toxicity. <i>Pediatrics</i>. 1986;77(4):593-597.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/3960626/pubmed" id="3960626" target="_blank">3960626</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  American Academy of Pediatric Dentistry (AAPD). Guideline on infant oral health care. 2012. http://www.aapd.org/media/Policies_Guidelines/G_infantOralHealthCare.pdf.</div>
</li>
<li>
<div class="reference">
                  American Academy of Pediatrics Oral Health Initiative (AAP). A Pediatric Guide to Children's Oral Health. January, 2011. http://www2.aap.org/commpeds/dochs/oralhealth/docs/OralHealthFCpagesF2_2_1.pdf.</div>
</li>
<li>
<div class="reference">
                  AvaDerm (lidocaine hydrochloride and menthol) [prescribing information]. Encino, CA: MAS Pharma; July 2015.</div>
</li>
<li>
<div class="reference">
                  AvaLin (lidocaine and menthol) [prescribing information]. Burbank, CA: RxChange Co; January 2015.</div>
</li>
<li>
<div class="reference">
                  CBD4 Freeze Pump (lidocaine and menthol) [prescribing information]. Jacksonville, FL: HMP Brands LLC; received November 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep. </i>1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6423951">
<a name="6423951"></a>Centers for Disease Control (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product. <i>MMWR Morb Mortal Wkly Rep</i>. 1984;33(14):198-199. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm</a>.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/6423951/pubmed" id="6423951" target="_blank">6423951</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Gen7T Plus Patch (lidocaine and menthol) [prescribing information]. Las Vegas, NV: 7T Pharma, LLC; December 2020.</div>
</li>
<li>
<div class="reference">
                  Icy Hot Lidocaine Plus Menthol (lidocaine and menthol) [prescribing information]. Chatanooga, TN: Chattem; received January 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-IcyHotMax.1">
<a name="IcyHotMax.1"></a>Icy Hot Max (lidocaine and menthol) [prescribing information]. Chatanooga, TN: Chattem; received December 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics.</i> 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12534540">
<a name="12534540"></a>Isaksson M, Jansson L. Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatitis</i>. 2002;47(5):312-313.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/12534540/pubmed" id="12534540" target="_blank">12534540</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  LenzaGel (lidocaine hydrochloride and menthol) [prescribing information]. Glendale, CA: Pharmaceutica North America; June 2014.</div>
</li>
<li>
<div class="reference">
                  LenzaPro Flex Patch (lidocaine hydrochloride/menthol) [prescribing information]. Baton Rouge, LA: Sola Pharmaceuticals; February 2021.</div>
</li>
<li>
<div class="reference">
                  LidoPatch Pain Relief (lidocaine and menthol) [prescribing information]. Elmhurst, IL: JAR Laboratories; received October 2017.</div>
</li>
<li>
<div class="reference">
                  LidoStream (lidocaine and menthol) [prescribing information]. Biloxi, MS: Upstream Pharma; October 2019.</div>
</li>
<li>
<div class="reference">
                  Lidothol gel (lidocaine and menthol) [prescribing information]. Reno, NV: Terrain Pharmaceuticals; received December 2023.</div>
</li>
<li>
<div class="reference">
                  Lidothol patch (lidocaine/menthol) [prescribing information]. Reno, NV: Terrain Pharmaceuticals; received December 2023.</div>
</li>
<li>
<div class="reference">
                  Lidotral (lidocaine and menthol) spray [prescribing information]. Panorama City, CA: PureTek Corporation; received November 2023.</div>
</li>
<li>
<div class="reference">
                  Lidozen Patch (lidocaine and menthol) [prescribing information]. Agoura Hills, CA: Village Pharma LLC; received October 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10985636">
<a name="10985636"></a>Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/10985636/pubmed" id="10985636" target="_blank">10985636</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7746084">
<a name="7746084"></a>Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. <i>Lancet</i>. 1995;345(8980):1312-1313.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-and-menthol-pediatric-drug-information/abstract-text/7746084/pubmed" id="7746084" target="_blank">7746084</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Siterol (lidocaine hydrochloride and menthol) [prescribing information]. Los Angeles, CA: Binger Consulting Corporation; May 2015.</div>
</li>
<li>
<div class="reference">
                  Synvexia TC (lidocaine hydrochloride and menthol) [prescribing information]. Ripley, MS: Sterling Knight Pharmaceuticals; December 2014.</div>
</li>
<li>
<div class="reference">
                  Terocin (lidocaine and menthol) [prescribing information]. Los Angeles, CA: Alexso Inc; July 2017.</div>
</li></ol></div><div id="topicVersionRevision">Topic 130875 Version 143.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
